Real-World Outcomes of Risk-Appropriate Treatments for Prostate Cancer

What is it about?

This study analyzed clinical and functional outcomes for 8,513 Australian men with localized prostate cancer, categorized by treatment type and risk level. The main outcomes measured were overall survival, cancer-specific survival, decline in functional outcomes, biochemical recurrence, and transition to active treatment following active surveillance. The results showed that overall and prostate cancer-specific survival rates were high across most risk and treatment categories. However, men with high-risk disease who underwent active surveillance or watchful waiting had poorer outcomes. The study also found that advancements in imaging and radical therapy techniques have led to improvements in functional and oncologic outcomes. The results indicated that the probability of each outcome for the average man facing decisions about prostate cancer treatments, and do not imply that men should choose one treatment over another. Clinician and patient considerations about treatment choices will depend on a range of factors including underlying medical conditions, cancer aggressiveness and extent of spread, personal circumstances, and patient preferences.

Featured Image

Why is it important?

This research is important as it provides real-world clinical and functional outcomes for men with localized prostate cancer in Australia, based on their risk category and treatment type. This information can help clinicians and patients make informed decisions about the most appropriate treatment options. Moreover, this study uses real-world data, which reflects the actual experiences of men diagnosed with prostate cancer, making it more relevant and practical for decision-making. Key Takeaways: 1. The study provides real-world clinical and functional outcomes for men with localized prostate cancer in Australia. 2. Overwhelmingly, the study findings indicated favorable survival outcomes across most risk and treatment categories. 3. The use of active surveillance increased for men with low-risk prostate cancer, while radical treatment rates decreased. 4. The study highlights the importance of considering both clinical and functional outcomes when making treatment decisions for men with prostate cancer. 5. Advancements in imaging and radical therapy techniques have likely led to improvements in functional and oncologic outcomes.